Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $224,884 |
| Sells | 27 | $3,505,350 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 12 Nov 2024 19:29 | AUPH | Aurinia Pharmaceuticals Inc | BAILEY JEFFREY ALLEN | Director | 11 Nov 2024 | Sale | 4,557 | 8.43 | 38,416 | D |
| 12 Nov 2024 19:20 | AUPH | Aurinia Pharmaceuticals Inc | SMITH KAREN L. | Director | 11 Nov 2024 | Sale | 5,241 | 8.43 | 44,182 | D |
| 08 Aug 2024 16:06 | AUPH | Aurinia Pharmaceuticals Inc | HABIG SCOTT MICHAEL | Chief Commercial Officer | 06 Aug 2024 | Sale | 18,249 | 5.31 | 96,902 | D |
| 22 May 2024 16:16 | AUPH | Aurinia Pharmaceuticals Inc | BALAKRISHNAN BRINDA | Director | 21 May 2024 | Sale | 520 | 5.74 | 2,985 | D |
| 22 May 2024 16:14 | AUPH | Aurinia Pharmaceuticals Inc | BILLEN DANIEL | Director | 21 May 2024 | Sale | 5,252 | 5.74 | 30,146 | D |
| 22 May 2024 16:11 | AUPH | Aurinia Pharmaceuticals Inc | JAYNE DAVID R.W. | Director | 21 May 2024 | Sale | 4,946 | 5.74 | 28,390 | D |
| 22 May 2024 16:09 | AUPH | Aurinia Pharmaceuticals Inc | LEVERSAGE JILL | Director | 21 May 2024 | Sale | 5,610 | 5.74 | 32,201 | D |
| 22 May 2024 16:07 | AUPH | Aurinia Pharmaceuticals Inc | MACKAY-DUNN R. HECTOR | Director | 21 May 2024 | Sale | 5,630 | 5.74 | 32,316 | D |
| 07 Mar 2024 16:46 | AUPH | Aurinia Pharmaceuticals Inc | GREENLEAF PETER | Chief Executive Officer | 06 Mar 2024 | Sale | 126,981 | 5.6 | 711,094 | D |
| 07 Mar 2024 16:44 | AUPH | Aurinia Pharmaceuticals Inc | MILLER JOSEPH M | Chief Financial Officer | 06 Mar 2024 | Sale | 34,811 | 5.6 | 194,942 | D |
| 07 Mar 2024 16:43 | AUPH | Aurinia Pharmaceuticals Inc | DONLEY MATTHEW MAXWELL | EVP, Ops & Strategy | 06 Mar 2024 | Sale | 40,665 | 5.51 | 224,064 | D |
| 07 Mar 2024 16:42 | AUPH | Aurinia Pharmaceuticals Inc | HABIG SCOTT MICHAEL | Chief Commercial Officer | 06 Mar 2024 | Sale | 17,777 | 5.6 | 99,551 | D |
| 07 Mar 2024 16:41 | AUPH | Aurinia Pharmaceuticals Inc | ROBERTSON STEPHEN P. | EVP, General Counsel | 06 Mar 2024 | Sale | 57,745 | 5.6 | 323,372 | D |
| 29 Feb 2024 16:11 | AUPH | Aurinia Pharmaceuticals Inc | KNAPPERTZ VOLKER | EVP, Research and Development | 27 Feb 2024 | Sale | 4,930 | 6.1 | 30,073 | D |
| 22 Feb 2024 16:35 | AUPH | Aurinia Pharmaceuticals Inc | KNAPPERTZ VOLKER | EVP, Research and Development | 20 Feb 2024 | Sale | 25,146 | 5.48 | 137,800 | D |
| 22 Feb 2024 16:33 | AUPH | Aurinia Pharmaceuticals Inc | HABIG SCOTT MICHAEL | Chief Commercial Officer | 20 Feb 2024 | Sale | 15,867 | 5.48 | 86,951 | D |
| 22 Feb 2024 16:19 | AUPH | Aurinia Pharmaceuticals Inc | ROBERTSON STEPHEN P. | EVP, General Counsel | 02 Mar 2023 | Sale A | 19,644 | 8.78 | 172,474 | D |
| 22 Feb 2024 16:17 | AUPH | Aurinia Pharmaceuticals Inc | MILLER JOSEPH M | Chief Financial Officer | 02 Mar 2023 | Sale A | 11,398 | 8.78 | 100,074 | D |
| 22 Feb 2024 16:15 | AUPH | Aurinia Pharmaceuticals Inc | GREENLEAF PETER | Chief Executive Officer | 02 Mar 2023 | Sale A | 33,047 | 8.78 | 290,153 | D |
| 23 May 2023 17:19 | AUPH | Aurinia Pharmaceuticals Inc | JAYNE DAVID R.W. | Director | 23 May 2023 | Sale | 8,733 | 11.26 | 98,334 | D |
| 23 May 2023 17:18 | AUPH | Aurinia Pharmaceuticals Inc | HAGAN JOSEPH P | Director | 19 May 2023 | Sale | 272 | 10.58 | 2,878 | D |
| 23 May 2023 17:17 | AUPH | Aurinia Pharmaceuticals Inc | BILLEN DANIEL | Director | 23 May 2023 | Sale | 4,650 | 11.26 | 52,359 | D |
| 23 May 2023 17:16 | AUPH | Aurinia Pharmaceuticals Inc | MACKAY-DUNN R. HECTOR | Director | 23 May 2023 | Sale | 4,818 | 11.26 | 54,251 | D |
| 23 May 2023 17:14 | AUPH | Aurinia Pharmaceuticals Inc | LEVERSAGE JILL | Director | 23 May 2023 | Sale | 4,815 | 11.26 | 54,217 | D |
| 06 Mar 2023 16:29 | AUPH | Aurinia Pharmaceuticals Inc | MILNE GEORGE M JR | Director | 02 Mar 2023 | Purchase | 20,000 | 8.9142 | 178,284 | D |
| 06 Mar 2023 16:29 | AUPH | Aurinia Pharmaceuticals Inc | MILLER JOSEPH M | Chief Financial Officer | 02 Mar 2023 | Sale | 11,296 | 8.94 | 100,986 | D |
| 06 Mar 2023 16:29 | AUPH | Aurinia Pharmaceuticals Inc | ROBERTSON STEPHEN P. | EVP, General Counsel | 02 Mar 2023 | Sale | 19,402 | 8.94 | 173,454 | D |
| 06 Mar 2023 16:27 | AUPH | Aurinia Pharmaceuticals Inc | GREENLEAF PETER | Chief Executive Officer | 02 Mar 2023 | Sale | 32,750 | 8.94 | 292,785 | D |
| 23 Nov 2022 16:04 | AUPH | Aurinia Pharmaceuticals Inc | DONLEY MATTHEW MAXWELL | Ex VP, Internal Operations | 21 Nov 2022 | Purchase | 10,000 | 4.66 | 46,600 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)